The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global genomics market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year. Increasing government funding in the field of microbiology and genetics is one of the major driving factors promoting the growth of the genomics market.
The global genomics market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the genomics industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
- North America to account for the highest share of the genomics market during the forecast period
- The consumables segment dominated the genomics market, by product & service, in 2019
- The PCR segment accounted for the largest share of the genomics market, by technology, in 2019
- Diagnostics forms the largest and fastest-growing application segment in the genomics market
- Rising research intensity to boost the usage of genomic systems among academic & government institutes
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1204
Market growth is driven by factors such as growing government funding and growth in the number of genomics projects, decreasing sequencing costs, increasing genomics application areas, and the entry of new players and start-ups into the genomics business. However the high cost of genomic equipment in the coming years may, to a certain degree, restrict market development. The key tool for the creation of successful therapies is genomic research, a primary reason why many government agencies are investing in a genome project. Traditional techniques of genome editing are time-consuming, costly, and labor-intensive and have a limited ability to keep pace with the age of rapidly advancing genome modification.
However, by enabling quick and accurate genome editing, the advent of CRISPR/Cas9 nuclease, ZFN, and TALEN is intended to overcome these challenges. Clinical healthcare is considered a pathway for U.S. citizens to adopt new sequencing technologies. This trend is powered by giants in healthcare concentrating on delivering medical genomics through the delivery of clinical patient care. Also through the detection of underlying mutations in an organism, newly developed gene-editing technologies can monitor and potentially cure specific diseases. During the forecast era, the rise in preference for modified medicine and the popularization of alliances between research institutes and businesses are expected to drive the growth in the market size of genomics.
Military organizations have drawn attention from continuous advances in genomics, culminating in a significant increase in the use of genetic engineering in their healthcare systems. During the forecast period, this increasing adoption of genomics from different sectors is expected to drive the growth of the size of the Genomics Market. In addition, growing investment by both public and private organizations in genetic research on personalized medicines is projected to increase the size of the genomics industry.
In 2018, North America accounted for the greatest share of the genomics market. The increase in research funding and government programs in genomics is due to the large share of North America. On the other hand, the Asia Pacific market is projected to report the highest CAGR during the forecast era. Owing to growing acceptance and understanding of the new genomics technologies in the developing countries of this region, Asia Pacific is expected to see the highest growth rate. The substantial growth in this field is due to an increased awareness of genomics and increased focus by the government on supporting research into genomics. Initiatives such as the launch of the Precision Medicine Initiative (PMI) for the use of genomics in healthcare in 2017 have played a key role in China’s regional market development.
Top Players Contending in the Market:
The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global genomics market are as follows:
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Oxford Nanopore Technologies
- QIAGEN N.V.
- Eurofins Scientific
- GE Healthcare
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
By Product and Services
- Systems and software
- Services Equipment
- PCR (polymerase chain reaction)
- Nucleic acid extraction and purification
- Other technologies (branched DNA analysis, single-cell genomics analysis, and flow cytometry)
- Drug discovery and development
- Precision medicine
- Agriculture and animal research
- Other applications
- Hospitals & clinics
- Research centers and academic & government institutes
- Pharmaceutical & biotechnology companies
- Other end users
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Some of the key highlights covered in the report include:
Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global genomics market. It examines trends and factors influencing demand for genomics globally and gauges the impact of the same on the production.
Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.
Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.
Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for genomics across the world.
Competitive Analysis – Some of the leading market players are profiled in the report on genomics. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.
COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.
Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.
Why should you invest in this report?
If you are aiming to enter the global genomics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for genomics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
Chapter 2. Research Methodology
2.1. Research Approach
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Genomics Market Variables and Scope
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Genomics Market
5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and GenomicsOpportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Genomics Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
18.104.22.168. Driver 1
22.214.171.124. Driver 2
6.1.2. Market Restraints
126.96.36.199. Restraint 1
6.1.3. Market Opportunities
188.8.131.52. Opportunity 1
184.108.40.206. Opportunity 2
Chapter 7. Global Genomics Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
220.127.116.11. Genomics Market Revenue by Market Players (2015-2020)
18.104.22.168. Genomics Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
22.214.171.124. Product Portfolio Expansion, Geographic Expansion, Product Innovation
126.96.36.199. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
188.8.131.52. List of Product Type Suppliers
184.108.40.206. List of End-users
Chapter 8. Global Genomics Market, By Product Type
8.1. Genomics Market, by Component, 2016-2027
220.127.116.11. Market Revenue and Forecast (2016-2027)
8.1.2. Systems and software
18.104.22.168. Market Revenue and Forecast (2016-2027)
8.1.3. Services Equipment
22.214.171.124. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Genomics Market, By Application
9.1. Genomics Market, by Application, 2016-2027
126.96.36.199. Market Revenue and Forecast (2016-2027)
188.8.131.52. Market Revenue and Forecast (2016-2027)
9.1.3. PCR (polymerase chain reaction)
184.108.40.206. Market Revenue and Forecast (2016-2027)
9.1.4. Nucleic acid extraction and purification
220.127.116.11. Market Revenue and Forecast (2016-2027)
18.104.22.168. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Genomics Market, By End-user
10.1. Genomics Market, by End-user, 2016-2027
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Agriculture and animal research
10.1.5. Other applications
Chapter 11. Global GenomicsMarket, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast by End-user (2016-2027)
22.214.171.124. Market Revenue Forecast (2016-2027)
126.96.36.199. Market Revenue Forecast (2016-2027)
11.2.1. Market Revenue Forecast by Product Type(2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast by End-user (2016-2027)
188.8.131.52. Market Revenue Forecast (2016-2027)
184.108.40.206. Market Revenue Forecast (2016-2027)
220.127.116.11. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
18.104.22.168. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast by End-user (2016-2027)
22.214.171.124. Market Revenue Forecast (2016-2027)
126.96.36.199. Market Revenue Forecast (2016-2027)
188.8.131.52. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
184.108.40.206. Market Revenue Forecast (2016-2027)
11.4.1. Market Revenue Forecast by Product Type(2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by End-user (2016-2027)
220.127.116.11. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
18.104.22.168. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by End-user (2016-2027)
22.214.171.124. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
126.96.36.199. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
188.8.131.52. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
184.108.40.206. Market Revenue Forecast (2016-2027)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
220.127.116.11. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
18.104.22.168. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
22.214.171.124. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
126.96.36.199. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
188.8.131.52. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
184.108.40.206. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
220.127.116.11. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
18.104.22.168. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
22.214.171.124. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
126.96.36.199. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1204
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.
Call: +1 9197 992 333